Tendon tears are a relevant concern for today’s national health systems because of their social impact and high recurrence rate. The current gold standard for fixing tendon tears is surgical repair; however, this strategy is not able to fully re-establish tendon integrity and functionality. Tissue engineering approaches aim at promoting tissue regeneration by delivering the opportune signals to the injured site combining biomaterials, cells and biochemical cues. Electrospinning is currently one of the most versatile polymer processing techniques that allows manufacturing of nano- and micro-fibres substrates. Such fibrous morphology is deemed to be an ideal substrate to convey topographical cues to cells. Here we evaluated the potential of polycaprolactone processed by means of electrospinning technology for tendon tissue engineering. Fibrous free-of-defects substrate with random and aligned fibres were successfully fabricated. Rat tenocytes were used to assess the cytocompatibility of the substrates for application as tendon tissue engineered devices. Tenocytes were able to proliferate and adapt to the substrates topography acquiring an elongated morphology, which is the precondition for oriented collagen deposition, when seeded on aligned fibres. Real time Polymerase Chain Reaction (Rt-PCR) also revealed the overall maintenance of tenocyte phenotype over 7 days culture. To verify suitability for in vivo implantation, the level of inflammatory cytokine genes expressed by THP-1 cells cultured in presence of electrospun polycaprolactone substrates was evaluated. Inflammatory response was limited. The novel preliminary in vitro work presented herein showing tenocytes compatibility and limited inflammatory cytokines synthesis suggests that electrospun polycaprolactone may be taken into consideration as substrate for tendon healing applications.
RileyG.Tendinopathy – from basic science to treatment. Nat Clin Pract Rheumatol2008;
4: 82–89.
2.
LongoUGBertonAPapapietroNet al.
Epidemiology, genetics and biological factors of rotator cuff tears. Med Sport Sci2012;
57: 1–9.
3.
ChenJXuJWangAet al.
Scaffolds for tendon and ligament repair: review of the efficacy of commercial products. Expert Rev Med Devices2009;
6: 61–73.
4.
YangGRothrauffBBTuanRS.Tendon and ligament regeneration and repair: clinical relevance and developmental paradigm. Birth Defect Res C2013;
99: 203–222.
5.
ZumsteinM. AJostBHempelJet al.
The clinical and structural long-term results of open repair of massive tears of the rotator cuff. J Bone Joint Surg Am2008;
90: 2423–2431.
6.
LeBTNWuXLLamPHet al.
Factors predicting rotator cuff retears: an analysis of 1000 consecutive rotator cuff repairs. Am J Sports Med2014;
42: 1134–1142.
7.
Gillespie RJ, Knapik DM, Akkus O. Biologic and synthetic grafts in the reconstruction of large to massive rotator cuff tears. J Am Acad Orthop Surg 2016; 24: 823–828.
8.
RodriguesMTReisRLGomesME.Engineering tendon and ligament tissues: present developments towards successful clinical products. J Tissue Eng Regen Med2013;
7: 673–686.
9.
HuangZ.A review on polymer nanofibers by electrospinning and their applications in nanocomposites. Compos Sci Technol2003;
63: 2223–2253.
10.
FullSMDelmanCGluckJMet al.
Effect of fiber orientation of collagen-based electrospun meshes on human fibroblasts for ligament tissue engineering applications. J Biomed Mater Res B Res2015;
103: 39–46.
11.
YinZChenXSongHet al.
Electrospun scaffolds for multiple tissues regeneration in vivo through topography dependent induction of lineage specific differentiation. Biomater Biomater2015;
44: 173–185.
12.
HodgkinsonTYuanX-FBayatA.Electrospun silk fibroin fiber diameter influences in vitro dermal fibroblast behavior and promotes healing of ex vivo wound models. J Tissue Eng2014;
5: 1–13.
13.
BaoJLvWSunYet al.
Electrospun antimicrobial microfibrous scaffold for annulus fibrosus tissue engineering. J Mater Sci2013;
48: 4223–4232.
14.
PanichpakdeeJPavasantPSupapholP.Electrospun cellulose acetate fiber mats containing emodin with potential for use as wound dressing. Chiang Mai J Sci2016;
43: 195–205.
Ebrahimi-HosseinzadehBPedramMHatamian-ZarmiAet al.
In vivo evaluation of gelatin/hyaluronic acid nanofiber as Burn-wound healing and its comparison with ChitoHeal gel. Fibers Polym2016;
17: 820–826.
17.
LiuWThomopoulosSXiaY.Electrospun nanofibers for regenerative medicine. Adv Healthc Mater2012;
1: 10–25.
18.
CipitriaASkeltonADargavilleTRet al.
Design, fabrication and characterization of PCL electrospun scaffolds – a review. J Mater Chem2011;
21: 9419–9453.
19.
SolimanSSantSNicholJWet al.
Controlling the porosity of fibrous scaffolds by modulating the fiber diameter and packing density. J Biomed Mater Res A2011;
96: 566–574.
20.
ChenMPatraPKLovettMLet al.
Role of electrospun fibre diameter and corresponding specific surface area (SSA) on cell attachment. J Tissue Eng Regen Med2010;
4: 524–531.
21.
BadamiASKrekeMRThompsonMSet al.
Effect of fiber diameter on spreading, proliferation, and differentiation of osteoblastic cells on electrospun poly(lactic acid) substrates. Biomaterials2006;
27: 596–606.
22.
TsuchiyaSYamabeMYamaguchiYet al.
Establishment and characterization of a human acute monocytic leukemia cell line (THP-1). Int J Cancer1980;
26: 171–176.
23.
ChanputWMesJJWichersHJ.THP-1 cell line: an in vitro cell model for immune modulation approach. Int Immunopharmacol2014;
23: 37–45.
24.
DemirciEAcarMPourdeyhimiBet al.
Computation of mechanical anisotropy in thermally bonded bicomponent fibre nonwovens. Comput Mater Sci2011;
52: 157–163.
25.
ChhanaACallonKEDrayMet al.
Interactions between tenocytes and monosodium urate monohydrate crystals: implications for tendon involvement in gout. Ann Rheum Dis2014;
73: 1737–1741.
26.
MussonDSLesageSCornishJ. In vitro evaluation of a novel non-mulberry silk scaffold for use in tendon regeneration. Tissue Eng Part A2015; 1–42.
27.
LivakKJSchmittgenTD.Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods2001;
25: 402–408.
28.
SchmittgenTDLivakKJ.Analyzing real-time PCR data by the comparative CT method. Nat Protoc2008;
3: 1101–1108.
29.
DaigneaultMPrestonJAMarriottHMet al. The identification of markers of macrophage differentiation in PMA-stimulated THP-1 cells and monocyte-derived macrophages. PLoS One;
5: 1–10.
30.
GeninMClementFFattaccioliAet al.
M1 and M2 macrophages derived from THP-1 cells differentially modulate the response of cancer cells to etoposide. BMC Cancer2015;
15: 577
31.
RawsonSCartmellSWongJ.Suture techniques for tendon repair; a comparative review. Muscles Ligaments Tendons J2013;
3: 220–228.
32.
GalatzLMBallCMTeefeySAet al.
The outcome and repair integrity of completely arthroscopically repaired large and massive rotator cuff tears. J Bone Joint Surg Am2004;
86–A: 219–224.
33.
ZhangXBogdanowiczDEriskenCet al.
Biomimetic scaffold design for functional and integrative tendon repair. J Shoulder Elb Surg2012;
21: 266–277.
34.
ThomopoulosSHattersleyGRosenVet al.
The localized expression of extracellular matrix components in healing tendon insertion sites: an in situ hybridization study. J Orthop Res2002;
20: 454–463.
35.
GimbelJAVan KleunenJPMehtaSet al.
Supraspinatus tendon organizational and mechanical properties in a chronic rotator cuff tear animal model. J Biomech2004;
37: 739–749.
36.
BenjaminMRalphsJR.Tendons and ligaments – an overview. Histol Histopathol1997;
12: 1135–1144.
37.
BhardwajNKunduSC.Electrospinning: a fascinating fiber fabrication technique. Biotechnol Adv2010;
28: 325–347.
38.
BeachleyVWenX.Effect of electrospinning parameters on the nanofiber diameter and length. Mater Sci Eng C Mater Biol Appl2011;
29: 663–668.
39.
LiW-JMauckRLCooperJAet al.
Engineering controllable anisotropy in electrospun biodegradable nanofibrous scaffolds for musculoskeletal tissue engineering. J Biomech2007;
40: 1686–1693.
40.
MengZXWangYSMaCet al.
Electrospinning of PLGA/gelatin randomly-oriented and aligned nanofibers as potential scaffold in tissue engineering. Mater Sci Eng C2010;
30: 1204–1210.
41.
KapoorACaporaliEHGKenisPJAet al.
Microtopographically patterned surfaces promote the alignment of tenocytes and extracellular collagen. Acta Biomater2010;
6: 2580–2589.
LaranjeiraMDominguesRMACosta-AlmeidaRet al.
3D mimicry of native-tissue-fiber architecture guides tendon-derived cells and adipose stem cells into artificial tendon constructs. Small2017;
13: 1–13.
44.
McNeillyCMBanesAJBenjaminMet al.
Tendon cells in vivo form a three dimensional network of cell processes linked by gap junctions. J Anat1996;
189: 593–600.
45.
TongWYShenWYeungCWet al.
Functional replication of the tendon tissue microenvironment by a bioimprinted substrate and the support of tenocytic differentiation of mesenchymal stem cells. Biomaterials2012;
33: 7686–7698.
46.
ZhuJLiJWangBet al.
The regulation of phenotype of cultured tenocytes by microgrooved surface structure. Biomaterials2010;
31: 6952–6958.
47.
BenjaminMRalphsJR.The cell and developmental biology of tendons and ligaments. Int Rev Cytol2000;
196: 85–130.
48.
RileyGPHarrallRLCawstonTEet al.
Tenascin-C and human tendon degeneration. Am J Pathol1996;
149: 933–943.
49.
DochevaDHunzikerEBFaRet al.
Tenomodulin is necessary for tenocyte proliferation and tendon maturation. Mol Cell Biol2005;
25: 699–705.
50.
EriksenHPajalaA.Increased content of type III collagen at the rupture site of human Achilles tendon. J Orthop Res2002;
20: 1352–1357.
51.
MurchisonNDPriceBAConnerDAet al.
Regulation of tendon differentiation by scleraxis distinguishes force-transmitting tendons from muscle-anchoring tendons. Development2007;
134: 2697–2708.
52.
MendiasCLGumucioJPBakhurinKIet al.
Physiological loading of tendons induces scleraxis expression in epitenon fibroblasts. J Orthop Res2012;
30: 606–612.
53.
NakashimaKZhouXKunkelGet al.
The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell2002;
108: 17–29.
54.
KomoriT.Regulation of bone development and extracellular matrix protein genes by RUNX2. Cell Tissue Res2010;
339: 189–195.
55.
HenrySPLiangSAkdemirKCet al.
The postnatal role of Sox9 in cartilage. J Bone Miner Res2012;
27: 2511–2525.
56.
KianiCHChenLIWuYAOJIet al.
Structure and function of aggrecan. Cell Res2002;
12: 19–32.
57.
ChaudhurySXiaZThakkarDet al.
Gene expression profiles of changes underlying different-sized human rotator cuff tendon tears. J Shoulder Elb Surg2016;
25: 1561–1570.
58.
CookJLFellerJABonarSFet al.
Abnormal tenocyte morphology is more prevalent than collagen disruption in asymptomatic athletes’ patellar tendons. J Orthop Res2004;
22: 334–338.
59.
BoehlerRGrahamJSheaL.Tissue engineering tools for modulation of the immune response. Biotechniques2011;
51: 239–240.
60.
SugimotoMASousaLPPinhoVet al. Resolution of inflammation: what controls its onset? Front Immunol 2016; 7: 1–14.
61.
LawrenceTGilroyDW.Chronic inflammation: a failure of resolution?Int J Exp Pathol2007;
88: 85–94.
62.
JärvinenMJózsaLKannusPet al.
Histopathological findings in chronic tendon disorders. Scand J Med Sci Sports1997;
7: 86–95.
63.
SchwendeHFitzkeEAmbsPet al.
Differences in the state of differentiation of THP-1 cells induced by phorbol ester and 1,25-dihydroxyvitamin D3. J Leukoc Biol1996;
59: 555–561.
64.
SchutteRJParisi-AmonAReichertWM.Cytokine profiling using monocytes/macrophages cultured on common biomaterials with a range of surface chemistries. J Biomed Mater Res A2009;
88: 128–139.
65.
FullerKPGasparDDelgadoLMet al.
Influence of porosity and pore shape on structural, mechanical and biological properties of poly ε -caprolactone electro- spun fibrous scaffolds. Nanomedicine2016;
11: 1031–1040.
66.
DinarelloCA.Biologic basis for interleukin-1 in disease. Blood1996;
87: 2095–2147.
67.
MaXYanWZhengHet al.
Regulation of IL-10 and IL-12 production and function in macrophages and dendritic cells. F1000Res2015;
4: 1–13.
68.
TrinchieriG.Interleukin-12: a cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes. Blood1994;
84: 4008–4027.
69.
TaubDDAnverMOppenheimJJet al.
T lymphocyte recruitment by interleukin-8 (IL-8): IL-8-induced degranulation of neutrophils releases potent chemoattractants for human T lymphocytes both in vitro and in vivo. J Clin Invest1996;
97: 1931–1941.
70.
BaggioliniMClark-LewisI.Interleukin-8, a chemotactic and inflammatory cytokine. FEBS Lett1992;
307: 97–101.
71.
ParameswaranNPatialS.Tumor necrosis factor-α signaling in macrophages. Immunobiology1996;
195: 477–490.
72.
RossolMHeineHMeuschUet al.
LPS-induced cytokine production in human monocytes and macrophages. Crit Rev Immunol2011;
31: 379–446.
73.
WahlSMWongHMcCartney-FrancisN.Role of growth factors in inflammation and repair. J Cell Biochem1989;
40: 193–199.
74.
AssoianRKFleurdelysBEStevensonHCet al.
Expression and secretion of type beta transforming growth factor by activated human macrophages. Proc Natl Acad Sci U S A1987;
84: 6020–6024.
75.
MartinezFOGordonSLocatiMet al.
Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression. J Immunol2006;
177: 7303–7311.
76.
BarrosMHMHauckFDreyerJHet al.
Macrophage polarisation: an immunohistochemical approach for identifying M1 and M2 macrophages. PLoS One2013;
8: 1–11.
77.
HamannWFlöterASchmutzlerWet al.
Characterization of a novel anti-inflammatory factor produced by RM3/1 macrophages derived from glucocorticoid treated human monocytes. Inflamm Res1995;
44: 535–540.
78.
BuechlerCRitterMOrsóEet al.
Regulation of scavenger receptor CD163 expression in human monocytes and macrophages by pro- and antiinflammatory stimuli. J Leukoc Biol2000;
67: 97–103.
79.
WoodwardSCBrewerPSMoatamedFet al.
The intracellular degradation of poly(tifilon-caprolactone). J Biomed Mater Res1985;
19: 437–444.
80.
LamCXFHutmacherDWSchantzJ-Tet al.
Evaluation of polycaprolactone scaffold degradation for 6 months in vitro and in vivo. J Biomed Mater Res A2009;
90: 906–919.
81.
SillimanCCWangM.The merits of in vitro versus in vivo modeling in investigation of the immune system. Environ Toxicol Pharmacol2006;
21: 123–134.
